Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q2 EPS by 17c

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q2 EPS of ($0.37), $0.17 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• This auto stock is a Top Pick at Citi
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance